Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Michael J. Schurr

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-IMM MICRO GENERAL OPER
Phone303/724-9375

    Collapse Biography 
    Collapse education and training
    Loyola University , New Orleans, LaB.S.05/1983Biological Sciences
    University of North Texas, Denton, TxPh.D.05/1992Molecular Biology
    University of Texas Health Science Center at San Antonio, San Antonio, TxPostdoctoral fellow05/1996Bacterial Pathognesis

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    R13AI183723     (SCHURR, MICHAEL JOHN)May 23, 2024 - Apr 30, 2027
    NIH
    68th Wind RIver Conference on Procaryotic Biology
    Role: Principal Investigator
    R21AI166805     (HORSWILL, ALEXANDER R)Jun 1, 2022 - May 31, 2025
    NIH
    Staphylococcus aureus and Pseudomonas aeruginosa interactions in wound pathogenesis
    Role: Co-Principal Investigator
    R21AI154360     (SCHURR, MICHAEL JOHN)Jun 8, 2020 - May 31, 2022
    NIH
    Targeted Nanogel based Therapies for Chronic Recurrent Urinary Tract Infections
    Role: Principal Investigator
         (Guess, Marsha)Jul 1, 2019 - Jun 30, 2021
    SPARK
    Novel Drug Delivery System to eradicate urinary tract infections.
    Role Description: The goal of this study is to develop a novel treatment for recurrent urinary tract infections using nanogels that are targeted towards intracellular bacteria.
    Role: Collaborator
    SCHURR1610     (Michael J. Schurr)Apr 1, 2017 - Sep 1, 2018
    Cystic Fibrosis Foundation
    Iron Acquisition of Mucoid Pseudomonas aeruginosa
    Role Description: Pseudomonas aeruginosa is a ubiquitous, opportunistic pathogen infecting individuals with cystic fibrosis (CF). Due to the uncanny antibiotic resistance, CF patients infected with Pseudomonas often have chronic infections with limited therapeutic options. Part of the ability to resist antibiotic treatment and clearance by the immune system is due to the ability of the organism to grow in a community termed a biofilm. A basic understanding of the pathogenic mechanisms utilized by this organism in a bioflm is needed for possible therapeutic targets. P. aeruginosa produces alginate, rhamnolipids, type IV pili and cyanide under biofilm growth conditions and all of these are controlled by a protein that regulates transcription, AlgR. Iron acquisition is also an important part of establishing and maintaining P. aeruginosa biofilms. In fact, alginate production increases as iron levels decrease. We have recently determined that AlgR phosphorylation controls iron acquisition molecules, termed siderophores. Moreover, we have also determined that AlgR phosphorylation is required in a murine acute pneumonia model. Our preliminary evidence also shows that these multiple phenotypes (twitching motility, alginate and siderophore production) are both oxygen- and AlgR-dependent. Together, these data indicate that the protein that phosphorylates AlgR, AlgZ/FimS, responds to oxygen, phosphorylates AlgR and activates iron acquisition molecules. Therapeutic inhibition of the AlgZR two-component system would shut down alginate production, twitching motility, and iron acquisition. The goals of this research are to determine how AlgZ senses oxygen and to determine which genes are specifically activated by AlgR to control iron acquisition.
    Role: Principle Investigator
    R21AI094487     (SCHURR, MICHAEL JOHN)Apr 1, 2012 - Mar 31, 2015
    NIH
    Control of Pseudomonas aeruginosa Quorum Sensing and Alginate
    Role: Principal Investigator
    R01AI050812     (SCHURR, MICHAEL JOHN)Feb 1, 2004 - Jan 31, 2010
    NIH
    Regulation of Ps. aeruginosa Virulence Factors by AlgR
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pires EM, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ, Manuel CA. Antibiotic Treatment of Corynebacterium bovis-associated Clinical Disease in NSG Mice. Comp Med. 2023 Dec 01; 73(6):461-465. PMID: 38103891.
      View in: PubMed
    2. Jenul C, Keim KC, Jens JN, Zeiler MJ, Schilcher K, Schurr MJ, Melander C, Phelan VV, Horswill AR. Pyochelin biotransformation by Staphylococcus aureus shapes bacterial competition with Pseudomonas aeruginosa in polymicrobial infections. Cell Rep. 2023 06 27; 42(6):112540. PMID: 37227819.
      View in: PubMed
    3. Taylor JZ, Fong DL, Habenicht LM, Fink MK, Leszczynski JK, Frank DN, Kofonow JM, Robertson CE, Nicklawsky AG, Schurr MJ, Manuel CA. Effects of Extended Cage Component Sanitation Interval on the Microenvironment, Health, and Gastrointestinal Microbiome of Rats (Rattus norvegicus). J Am Assoc Lab Anim Sci. 2023 05 01; 62(3):212-221. PMID: 37072181.
      View in: PubMed
    4. Manuel CA, Pearson EC, Pugazhenthi U, Fink MK, Habenicht LM, Fong DL, Leszczynski JK, Schurr MJ. A Clinical Scoring Systems for the Evaluation of Corynebacterium bovis -associated Disease in NSG Mice. Comp Med. 2022 12 01; 72(6):386-393. PMID: 36744509.
      View in: PubMed
    5. Manuel CA, Johnson LK, Pugazhenthi U, Fong DL, Fink M, Habenicht LM, Leszczynski JK, Diana IR, Schurr MJ, Frank DN. Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice. Comp Med. 2022 04 01; 72(2):78-89. PMID: 35379380.
      View in: PubMed
    6. Trivedi R, Gautam D, Kehe GM, Escobedo HD, Patel K, Stansbury JW, Schurr MJ, Nair DP. Synthesis, characterization and evaluation of azobenzene nanogels for their antibacterial properties in adhesive dentistry. Eur J Oral Sci. 2022 02; 130(1):e12832. PMID: 34923692.
      View in: PubMed
    7. Mori DI, Powell A, Kehe GM, Schurr MJ, Nair DP, Puranik CP. Acrylated Hydroxyazobenzene Copolymers in Composite-Resin Matrix Inhibits Streptococcus mutans Biofilms In Vitro. Pediatr Dent. 2021 Nov 15; 43(6):484-491. PMID: 34937621.
      View in: PubMed
    8. Misischia WP, Xenoudi P, Yukna RA, Schurr MJ. Correction to: Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro. Lasers Med Sci. 2021 Oct; 36(8):1769. PMID: 34427850.
      View in: PubMed
    9. Misischia WP, Xenoudi P, Yukna RA, Schurr MJ. Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro. Lasers Med Sci. 2021 Oct; 36(8):1759-1767. PMID: 34313893.
      View in: PubMed
    10. Hassett DJ, Kovall RA, Schurr MJ, Kotagiri N, Kumari H, Satish L. The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections. Front Microbiol. 2021; 12:639362. PMID: 34220733.
      View in: PubMed
    11. Fagre AC, Pugazhenthi U, Cheleuitte-Nieves C, Crim MJ, Henderson KS, Fong DL, Leszczynski JK, Schurr MJ, Daniels JB, Manuel CA. Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents. Comp Med. 2021 06 01; 71(3):210-214. PMID: 33836843.
      View in: PubMed
    12. Bogue AL, Panmanee W, McDaniel CT, Mortensen JE, Kamau E, Actis LA, Johannigman JA, Schurr MJ, Satish L, Kotagiri N, Hassett DJ. AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp. PLoS One. 2021; 16(3):e0247513. PMID: 33657146.
      View in: PubMed
    13. Bernard M, Martin MJ, Corsa J, Robinson B, Zeeshan M, Joseph B, Morris D, Shillinglaw W, Schurr M, Smith T, Lara S, Brown C, Harrell K, Maxwell R, Berndtson AE, Curry T, Kaups K, Dirks R, Rott M, Schroeppel T, Stillman Z, Warriner Z, Inaba K, Burlew C, Robinson C, Jackson R, Dunn J, Chapin T, Wilson A, Moulton S, Phillips R, Shahi N, Urban S, Velopulos C, Davenport D, C Bernard A. Into the wild and on to the table: A Western Trauma Association multicenter analysis and comparison of wilderness falls in rock climbers and nonclimbers. J Trauma Acute Care Surg. 2020 09; 89(3):570-575. PMID: 32265389.
      View in: PubMed
    14. Mori DI, Schurr MJ, Nair DP. Selective Inhibition of Streptococci Biofilm Growth via a Hydroxylated Azobenzene Coating. Adv Mater Interfaces. 2020 Aug 06; 7(15). PMID: 33575161.
      View in: PubMed
    15. Schurr MJ. Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus? J Bacteriol. 2020 03 26; 202(8). PMID: 32015142.
      View in: PubMed
    16. McDaniel CT, Panmanee W, Winsor GL, Gill E, Bertelli C, Schurr MJ, Dongare P, Paul AT, Ko SB, Lau GW, Dasgupta N, Bogue AL, Miller WE, Mortensen JE, Haslam DB, Dexheimer P, Muruve DA, Aronow BJ, Forbes MDE, Danilczuk M, Brinkman FSL, Hancock REW, Meyer TJ, Hassett DJ. AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria. Proc Natl Acad Sci U S A. 2020 03 03; 117(9):4921-4930. PMID: 32071223.
      View in: PubMed
    17. Mitchell CM, McGrath A, Beck B, Schurr MJ, Fong D, Leszczynski JK, Manuel CA. Low-cost, Small-scale Decontamination of Laboratory Equipment by Using Chlorine Dioxide Gas. J Am Assoc Lab Anim Sci. 2019.
      View Publication
    18. Kehe, G.M., Mori, D., Schurr, M.J. and D.P. Nair. Optically responsive, smart anti-bacterial coatings via photofluidization of azobenzenes. ACS Appl Mater Interface. 2019.
      View Publication
    19. Ashraf H, Font K, Powell C, Schurr M. Antimicrobial Activity of an Amnion-Chorion Membrane to Oral Microbes. Int J Dent. 2019; 2019:1269534. PMID: 31379946.
      View in: PubMed
    20. Panmanee W, Su S, Schurr MJ, Lau GW, Zhu X, Ren Z, McDaniel CT, Lu LJ, Ohman DE, Muruve DA, Panos RJ, Yu HD, Thompson TB, Tseng BS, Hassett DJ. The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ?mucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection. PLoS One. 2019; 14(6):e0216401. PMID: 31158231.
      View in: PubMed
    21. Little AS, Okkotsu Y, Reinhart AA, Damron FH, Barbier M, Barrett B, Oglesby-Sherrouse AG, Goldberg JB, Cody WL, Schurr MJ, Vasil ML, Schurr MJ. Pseudomonas aeruginosa AlgR Phosphorylation Status Differentially Regulates Pyocyanin and Pyoverdine Production. mBio. 2018 01 30; 9(1). PMID: 29382736.
      View in: PubMed
    22. Heacock-Kang Y, Sun Z, Zarzycki-Siek J, McMillan IA, Norris MH, Bluhm AP, Cabanas D, Fogen D, Vo H, Donachie SP, Borlee BR, Sibley CD, Lewenza S, Schurr MJ, Schweizer HP, Hoang TT. Spatial transcriptomes within the Pseudomonas aeruginosa biofilm architecture. Mol Microbiol. 2017 Dec; 106(6):976-985. PMID: 29030956.
      View in: PubMed
    23. Bartek IL, Reichlen MJ, Honaker RW, Leistikow RL, Clambey ET, Scobey MS, Hinds AB, Born SE, Covey CR, Schurr MJ, Lenaerts AJ, Voskuil MI. Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis. mSphere. 2016 Jul-Aug; 1(4). PMID: 27579369.
      View in: PubMed
    24. Grover N, Plaks JG, Summers SR, Chado GR, Schurr MJ, Kaar JL. Acylase-containing polyurethane coatings with anti-biofilm activity. Biotechnol Bioeng. 2016 12; 113(12):2535-2543. PMID: 27240552.
      View in: PubMed
    25. Pritchett CL, Little AS, Okkotsu Y, Frisk A, Cody WL, Covey CR, Schurr MJ. Expression analysis of the Pseudomonas aeruginosa AlgZR two-component regulatory system. J Bacteriol. 2015 Feb 15; 197(4):736-48. PMID: 25488298.
      View in: PubMed
    26. Okkotsu Y, Little AS, Schurr MJ. The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes. Front Cell Infect Microbiol. 2014; 4:82. PMID: 24999454.
      View in: PubMed
    27. Su S, Panmanee W, Wilson JJ, Mahtani HK, Li Q, Vanderwielen BD, Makris TM, Rogers M, McDaniel C, Lipscomb JD, Irvin RT, Schurr MJ, Lancaster JR, Kovall RA, Hassett DJ. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS One. 2014; 9(3):e91813. PMID: 24663218.
      View in: PubMed
    28. Chambers JR, Liao J, Schurr MJ, Sauer K. BrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factor. Mol Microbiol. 2014 May; 92(3):471-87. PMID: 24612375.
      View in: PubMed
    29. Wiens JR, Vasil AI, Schurr MJ, Vasil ML. Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa. mBio. 2014 Feb 04; 5(1):e01010-13. PMID: 24496793.
      View in: PubMed
    30. Yin Y, Damron FH, Withers TR, Pritchett CL, Wang X, Schurr MJ, Yu HD. Expression of mucoid induction factor MucE is dependent upon the alternate sigma factor AlgU in Pseudomonas aeruginosa. BMC Microbiol. 2013 Oct 18; 13:232. PMID: 24138584.
      View in: PubMed
    31. Okkotsu Y, Tieku P, Fitzsimmons LF, Churchill ME, Schurr MJ. Pseudomonas aeruginosa AlgR phosphorylation modulates rhamnolipid production and motility. J Bacteriol. 2013 Dec; 195(24):5499-515. PMID: 24097945.
      View in: PubMed
    32. Damron FH, Barbier M, McKenney ES, Schurr MJ, Goldberg JB. Genes required for and effects of alginate overproduction induced by growth of Pseudomonas aeruginosa on Pseudomonas isolation agar supplemented with ammonium metavanadate. J Bacteriol. 2013 Sep; 195(18):4020-36. PMID: 23794622.
      View in: PubMed
    33. Liao J, Schurr MJ, Sauer K. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J Bacteriol. 2013 Aug; 195(15):3352-63. PMID: 23687276.
      View in: PubMed
    34. Yuta Okkotsu, Christopher L. Pritchett and Michael J. Schurr. . Regulation of Exopolysaccharide biosynthesis in Pseudomonas aeruginosa. M.L. Vasil and A. Darwin. Regulation of Bacterial Virulence. Washington D.C. p. 171-189. 2013. 2013.
    35. Schurr MJ. Which bacterial biofilm exopolysaccharide is preferred, Psl or alginate? J Bacteriol. 2013 Apr; 195(8):1623-6. PMID: 23417492.
      View in: PubMed
    36. Petrova OE, Schurr JR, Schurr MJ, Sauer K. Microcolony formation by the opportunistic pathogen Pseudomonas aeruginosa requires pyruvate and pyruvate fermentation. Mol Microbiol. 2012 Nov; 86(4):819-35. PMID: 22931250.
      View in: PubMed
    37. Damron FH, Owings JP, Okkotsu Y, Varga JJ, Schurr JR, Goldberg JB, Schurr MJ, Yu HD. Analysis of the Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and sigma factor RpoN. J Bacteriol. 2012 Mar; 194(6):1317-30. PMID: 22210761.
      View in: PubMed
    38. Petrova OE, Schurr JR, Schurr MJ, Sauer K. The novel Pseudomonas aeruginosa two-component regulator BfmR controls bacteriophage-mediated lysis and DNA release during biofilm development through PhdA. Mol Microbiol. 2011 Aug; 81(3):767-83. PMID: 21696457.
      View in: PubMed
    39. Kuang Z, Hao Y, Hwang S, Zhang S, Kim E, Akinbi HT, Schurr MJ, Irvin RT, Hassett DJ, Lau GW. The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing. Mol Microbiol. 2011 Mar; 79(5):1220-35. PMID: 21205009.
      View in: PubMed
    40. Crabb? A, Schurr MJ, Monsieurs P, Morici L, Schurr J, Wilson JW, Ott CM, Tsaprailis G, Pierson DL, Stefanyshyn-Piper H, Nickerson CA. Transcriptional and proteomic responses of Pseudomonas aeruginosa PAO1 to spaceflight conditions involve Hfq regulation and reveal a role for oxygen. Appl Environ Microbiol. 2011 Feb; 77(4):1221-30. PMID: 21169425.
      View in: PubMed
    41. Jones AK, Fulcher NB, Balzer GJ, Urbanowski ML, Pritchett CL, Schurr MJ, Yahr TL, Wolfgang MC. Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling. J Bacteriol. 2010 Nov; 192(21):5709-17. PMID: 20817772.
      View in: PubMed
    42. Hassett DJ, Korfhagen TR, Irvin RT, Schurr MJ, Sauer K, Lau GW, Sutton MD, Yu H, Hoiby N. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin Ther Targets. 2010 Feb; 14(2):117-30. PMID: 20055712.
      View in: PubMed
    43. Kang Y, Lunin VV, Skarina T, Savchenko A, Schurr MJ, Hoang TT. The long-chain fatty acid sensor, PsrA, modulates the expression of rpoS and the type III secretion exsCEBA operon in Pseudomonas aeruginosa. Mol Microbiol. 2009 Jul; 73(1):120-36. PMID: 19508282.
      View in: PubMed
    44. Cody WL, Pritchett CL, Jones AK, Carterson AJ, Jackson D, Frisk A, Wolfgang MC, Schurr MJ. Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner. J Bacteriol. 2009 May; 191(9):2993-3002. PMID: 19270096.
      View in: PubMed
    45. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 2009 Mar; 17(3):130-8. PMID: 19231190.
      View in: PubMed
    46. Wilson JW, Ott CM, Quick L, Davis R, H?ner zu Bentrup K, Crabb? A, Richter E, Sarker S, Barrila J, Porwollik S, Cheng P, McClelland M, Tsaprailis G, Radabaugh T, Hunt A, Shah M, Nelman-Gonzalez M, Hing S, Parra M, Dumars P, Norwood K, Bober R, Devich J, Ruggles A, CdeBaca A, Narayan S, Benjamin J, Goulart C, Rupert M, Catella L, Schurr MJ, Buchanan K, Morici L, McCracken J, Porter MD, Pierson DL, Smith SM, Mergeay M, Leys N, Stefanyshyn-Piper HM, Gorie D, Nickerson CA. Media ion composition controls regulatory and virulence response of Salmonella in spaceflight. PLoS One. 2008; 3(12):e3923. PMID: 19079590.
      View in: PubMed
    47. Cody WL, Wilson JW, Hendrixson DR, McIver KS, Hagman KE, Ott CM, Nickerson CA, Schurr MJ. Skim milk enhances the preservation of thawed -80 degrees C bacterial stocks. J Microbiol Methods. 2008 Sep; 75(1):135-8. PMID: 18573555.
      View in: PubMed
    48. Platt MD, Schurr MJ, Sauer K, Vazquez G, Kukavica-Ibrulj I, Potvin E, Levesque RC, Fedynak A, Brinkman FS, Schurr J, Hwang SH, Lau GW, Limbach PA, Rowe JJ, Lieberman MA, Barraud N, Webb J, Kjelleberg S, Hunt DF, Hassett DJ. Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J Bacteriol. 2008 Apr; 190(8):2739-58. PMID: 18203836.
      View in: PubMed
    49. Wilson JW, Ott CM, H?ner zu Bentrup K, Ramamurthy R, Quick L, Porwollik S, Cheng P, McClelland M, Tsaprailis G, Radabaugh T, Hunt A, Fernandez D, Richter E, Shah M, Kilcoyne M, Joshi L, Nelman-Gonzalez M, Hing S, Parra M, Dumars P, Norwood K, Bober R, Devich J, Ruggles A, Goulart C, Rupert M, Stodieck L, Stafford P, Catella L, Schurr MJ, Buchanan K, Morici L, McCracken J, Allen P, Baker-Coleman C, Hammond T, Vogel J, Nelson R, Pierson DL, Stefanyshyn-Piper HM, Nickerson CA. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci U S A. 2007 Oct 09; 104(41):16299-304. PMID: 17901201.
      View in: PubMed
    50. Morici LA, Carterson AJ, Wagner VE, Frisk A, Schurr JR, H?ner zu Bentrup K, Hassett DJ, Iglewski BH, Sauer K, Schurr MJ. Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner. J Bacteriol. 2007 Nov; 189(21):7752-64. PMID: 17766417.
      View in: PubMed
    51. Yoon SS, Karabulut AC, Lipscomb JD, Hennigan RF, Lymar SV, Groce SL, Herr AB, Howell ML, Kiley PJ, Schurr MJ, Gaston B, Choi KH, Schweizer HP, Hassett DJ. Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration. EMBO J. 2007 Aug 08; 26(15):3662-72. PMID: 17627281.
      View in: PubMed
    52. C. A. Nickerson and M. J. Schurr (eds.). Molecular Paradigms of Infectious Disease: A Bacterial Perspective. 2006.
    53. Morici, L. A., Frisk, A. and M. J. Schurr. . Two Component Regulatory Systems. In Molecular Paradigms of Infectious Disease: A Bacterial Perspective. C. A. Nickerson and M. J. Schurr (eds.). Springer publisher, New York, NY. p. 502-543. 2006. 2006.
    54. Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang SH, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest. 2006 Feb; 116(2):436-46. PMID: 16440061.
      View in: PubMed
    55. Carterson AJ, H?ner zu Bentrup K, Ott CM, Clarke MS, Pierson DL, Vanderburg CR, Buchanan KL, Nickerson CA, Schurr MJ. A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect Immun. 2005 Feb; 73(2):1129-40. PMID: 15664956.
      View in: PubMed
    56. Carterson AJ, Morici LA, Jackson DW, Frisk A, Lizewski SE, Jupiter R, Simpson K, Kunz DA, Davis SH, Schurr JR, Hassett DJ, Schurr MJ. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol. 2004 Oct; 186(20):6837-44. PMID: 15466037.
      View in: PubMed
    57. Lizewski SE, Schurr JR, Jackson DW, Frisk A, Carterson AJ, Schurr MJ. Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis. J Bacteriol. 2004 Sep; 186(17):5672-84. PMID: 15317771.
      View in: PubMed
    58. Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, Hwang SH, Hassett DJ, Schurr MJ. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect Immun. 2004 Sep; 72(9):5433-8. PMID: 15322041.
      View in: PubMed
    59. Hassett, D. J., Lymar, S. V., Rowe, J. J., Schurr, M. J., Passador, L., Herr, A. B., Yoon, S. S., Lau, G. W., Winsor, G. L. and F. S. L. Brinkman. . Anaerobic metabolism by Pseudomonas aeruginosa in cystic fibrosis airway biofilms: Role of nitric oxide, quorum sensing and alginate production In: Strict and Facultative Anaerobes:Medical and Environmental Aspects. CRC Press, Boca Raton, FL. p. 87-109. 2004. 2004.
    60. Dang YN, Rao A, Kastl PR, Blake RC, Schurr MJ, Blake DA. Quantifying Pseudomonas aeruginosa adhesion to contact lenses. Eye Contact Lens. 2003 Apr; 29(2):65-8. PMID: 12695704.
      View in: PubMed
    61. Lizewski SE, Lundberg DS, Schurr MJ. The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis. Infect Immun. 2002 Nov; 70(11):6083-93. PMID: 12379685.
      View in: PubMed
    62. Wilson JW, Schurr MJ, LeBlanc CL, Ramamurthy R, Buchanan KL, Nickerson CA. Mechanisms of bacterial pathogenicity. Postgrad Med J. 2002 Apr; 78(918):216-24. PMID: 11930024.
      View in: PubMed
    63. Boucher JC, Schurr MJ, Deretic V. Dual regulation of mucoidy in Pseudomonas aeruginosa and sigma factor antagonism. Mol Microbiol. 2000 Apr; 36(2):341-51. PMID: 10792721.
      View in: PubMed
    64. Boucher JC, Schurr MJ, Yu H, Rowen DW, Deretic V. Pseudomonas aeruginosa in cystic fibrosis: role of mucC in the regulation of alginate production and stress sensitivity. Microbiology (Reading). 1997 Nov; 143 ( Pt 11):3473-3480. PMID: 9387225.
      View in: PubMed
    65. Schurr MJ, Deretic V. Microbial pathogenesis in cystic fibrosis: co-ordinate regulation of heat-shock response and conversion to mucoidy in Pseudomonas aeruginosa. Mol Microbiol. 1997 Apr; 24(2):411-20. PMID: 9159526.
      View in: PubMed
    66. Yu H, Mudd M, Boucher JC, Schurr MJ, Deretic V. Identification of the algZ gene upstream of the response regulator algR and its participation in control of alginate production in Pseudomonas aeruginosa. J Bacteriol. 1997 Jan; 179(1):187-93. PMID: 8981997.
      View in: PubMed
    67. Schurr MJ, Yu H, Martinez-Salazar JM, Boucher JC, Deretic V. Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J Bacteriol. 1996 Aug; 178(16):4997-5004. PMID: 8759866.
      View in: PubMed
    68. Yu, H., Schurr, M. J., Boucher, J. C., Martinez-Salazar, J. M., Martin, D. W. and V. Deretic. Pseudomonas:. Molecular mechanism of conversion to mucoidy in Pseudomonas aeruginosa,. 1996; 384-397.
    69. Boucher JC, Martinez-Salazar J, Schurr MJ, Mudd MH, Yu H, Deretic V. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol. 1996 Jan; 178(2):511-23. PMID: 8550474.
      View in: PubMed
    70. Schurr MJ, Yu H, Martinez-Salazar JM, Hibler NS, Deretic V. Biochemical characterization and posttranslational modification of AlgU, a regulator of stress response in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1995 Nov 22; 216(3):874-80. PMID: 7488207.
      View in: PubMed
    71. Schurr MJ, Yu H, Boucher JC, Hibler NS, Deretic V. Multiple promoters and induction by heat shock of the gene encoding the alternative sigma factor AlgU (sigma E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J Bacteriol. 1995 Oct; 177(19):5670-9. PMID: 7559357.
      View in: PubMed
    72. Deretic V, Schurr MJ, Yu H. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. Trends Microbiol. 1995 Sep; 3(9):351-6. PMID: 8520888.
      View in: PubMed
    73. Yu H, Schurr MJ, Deretic V. Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J Bacteriol. 1995 Jun; 177(11):3259-68. PMID: 7768826.
      View in: PubMed
    74. Schurr MJ, Vickrey JF, Kumar AP, Campbell AL, Cunin R, Benjamin RC, Shanley MS, O'Donovan GA. Aspartate transcarbamoylase genes of Pseudomonas putida: requirement for an inactive dihydroorotase for assembly into the dodecameric holoenzyme. J Bacteriol. 1995 Apr; 177(7):1751-9. PMID: 7896697.
      View in: PubMed
    75. Martin DW, Schurr MJ, Yu H, Deretic V. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response. J Bacteriol. 1994 Nov; 176(21):6688-96. PMID: 7961422.
      View in: PubMed
    76. Schurr MJ, Martin DW, Mudd MH, Deretic V. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J Bacteriol. 1994 Jun; 176(11):3375-82. PMID: 8195094.
      View in: PubMed
    77. Deretic V, Schurr MJ, Boucher JC, Martin DW. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J Bacteriol. 1994 May; 176(10):2773-80. PMID: 8188579.
      View in: PubMed
    78. Deretic V, Martin DW, Schurr MJ, Mudd MH, Hibler NS, Curcic R, Boucher JC. Conversion to mucoidy in Pseudomonas aeruginosa. Biotechnology (N Y). 1993 Oct; 11(10):1133-6. PMID: 7764093.
      View in: PubMed
    79. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A. 1993 Sep 15; 90(18):8377-81. PMID: 8378309.
      View in: PubMed
    80. Martin DW, Schurr MJ, Mudd MH, Deretic V. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol Microbiol. 1993 Aug; 9(3):497-506. PMID: 8412698.
      View in: PubMed
    81. Schurr MJ, Martin DW, Mudd MH, Hibler NS, Boucher JC, Deretic V. The algD promoter: regulation of alginate production by Pseudomonas aeruginosa in cystic fibrosis. Cell Mol Biol Res. 1993; 39(4):371-6. PMID: 8312973.
      View in: PubMed
    82. Zimmerman EG, Akins DR, Planz JV, Schurr MJ. A rapid procedure for isolating mitochondrial DNA. Gene Anal Tech. 1988 Sep-Oct; 5(5):102-4. PMID: 2847966.
      View in: PubMed
    Schurr's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (318) concept(s)
    _
    Co-Authors Expand Description
    See all (23) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)